Merck news

Niaspan tops Zetia in new setback for Merck drug

Study deals blow to Merck cholesterol pill Zetia

WSBT-TV - 31 minutes ago
By Jason Overholt ORLANDO, Fla. (AP) — A new study raises fresh concerns about Zetia and its cousin, Vytorin — drugs that are still taken by millions of Americans to lower cholesterol, despite ...

Stocks That Are Better Than Gold

The Money Times - 35 minutes ago
by Selena Maranjian - November 15, 2009 - 0 comments Stocks are tied to tangible things, too: actual bricks-and-mortar companies. Merck (NYSE: MRK) stock is tied to Merck buildings and Merck ...

Merck (MRK) Drugs Under Scanner Of Cholesterol Study

Benzinga - 31 minutes ago
Merck & Co., Inc. (NYSE: MRK) is likely to be impacted by a new cholesterol study that has its multibillion cholesterol medications under the scanner. Analysts are flying down to Orlando, Fla ...

Merck (MRK) Announces Completion of TRA 2˚P-TIMI 50 Clinical

Selling medicines under generic names could bring down their prices

Trading Markets - 9 minutes ago
KARACHI, Nov 12, 2009 (Asia Pulse Data Source via COMTEX) -- RBGPF -- The selling of most drugs under a trade or brand names raising a controversy of variance in drug prices which produces of the ...

New Merck Begins Operations Worldwide

Bernama - 22 minutes ago
KUALA LUMPUR, Nov 13 (Bernama) -- Global healthcare leader Merck & Co has outlined its global strategy following the completion of its recent merger with Schering-Plough Corporation. The new Merck ...

Merck Eprova signs license agreement with Isofol Medical for Modufolin(R)

Trading Markets - 22 minutes ago
Nov 12, 2009 (Datamonitor Financial Deals Tracker via COMTEX) -- MKGAY -- Merck Eprova AG has signed an exclusive license agreement with Isofol Medical AB, a Sweden-based developer of new method ...